XGX Pharma ApS: Financial statements 2012
CVR: 32289290
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
XGX Pharma ApS (CVR 32289290) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 83,774 and a net result of DKK 96,450. Equity in the 2012 report amounted to DKK -14,277.
- Gross Profit
- DKK 83,774
- Profit/Loss
- DKK 96,450
- Equity
- DKK -14,277
- Total Assets
- DKK 66,353
Official annual report
Keep an eye on XGX Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout XGX Pharma ApS
XGX Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens-Nikolaj Schøier. The board consists of Per Anders Larnholt (chair) and Johan Frödin. The company is owned by Unimedic Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 32,338,381 and a net result of DKK 16,074,119 compared with DKK 4,453,433 the year before. Equity in the 2025 report amounted to DKK 30,787,180.